NTERA-2
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-527, RRID:CVCL_0034
|
Homo sapiens (Human)
|
Embryonal carcinoma
|
Population: Caucasian., Part of: Human Protein Atlas, Cell Atlas panel.
|
PMID:3293662 PMID:6694356 PMID:16919167 PMID:16957166 PMID:25485619 PMID:25877200 PMID:26589293 PMID:35084545
|
Cancer cell line
|
Male |
NTera-2, Ntera-2, NTera 2, NTERA2, NTera2, N-Tera-2, NT-2, NT2 |
DSMZ |
ACC-527 |
BTO:BTO_0000891, CLO:CLO_0008208, EFO:EFO_0002959, ArrayExpress:E-MTAB-2706, BioSample:SAMN03472969, CCRID:1101HUM-PUMC000019, ChEMBL-Cells:CHEMBL3308505, ChEMBL-Targets:CHEMBL614205, Cosmic:821809, Cosmic:2439936, Cosmic:2560242, Cosmic:2806394, Cosmic:2807075, DSMZ:ACC-527, DSMZCellDive:ACC-527, EGA:EGAS00001000610, GEO:GSM7701436, GEO:GSM7701437, IBRC:C10509, PharmacoDB:NTERA2_1167_2019, PRIDE:PXD030251, PubChem_Cell_line:CVCL_0034, RSCB:RSCB0150, Wikidata:Q17092091 |
cvcl_2777 |
|
CVCL_0034 |
2026-09-12 05:56:32 |
4 |
NU-DUL-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1877
|
Homo sapiens (Human)
|
Diffuse large B-cell lymphoma activated B-cell type
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2581902 PMID:19278952 PMID:22460905 PMID:23699601 PMID:25355872 PMID:25485619 PMID:25960936 PMID:26589293 PMID:27397505 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
NUDUL-1, NUDUL1 |
|
|
BTO:BTO_0006480, CLO:CLO_0037051, EFO:EFO_0006700, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2969, BioSample:SAMN03473485, BioSample:SAMN10988580, cancercelllines:CVCL_1877, Cell_Model_Passport:SIDM00443, ChEMBL-Cells:CHEMBL4523589, ChEMBL-Targets:CHEMBL4523592, Cosmic:1629936, Cosmic-CLP:1330982, DepMap:ACH-000287, DSMZ:ACC-579, DSMZCellDive:ACC-579, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1330982, GEO:GSM887460, GEO:GSM888540, GEO:GSM1035320, GEO:GSM1670286, IARC_TP53:28303, LiGeA:CCLE_504, LINCS_LDP:LCL-1132, PharmacoDB:NUDUL1_1171_2019, PRIDE:PXD030304, Progenetix:CVCL_1877, PubChem_Cell_line:CVCL_1877, Wikidata:Q54931149 |
|
|
CVCL_1877 |
2026-09-12 05:56:33 |
5 |
NUGC-2
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1611
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1778766 PMID:3172586 PMID:3986962 PMID:9290701 PMID:15723654 PMID:19132987 PMID:22460905 PMID:24807215 PMID:25485619 PMID:25877200 PMID:26589293 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Female |
NuGC-2, NUGC2, NU-GC-2, Nagoya University-Gastric Cancer-2 |
|
|
BTO:BTO_0002596, CLO:CLO_0037143, EFO:EFO_0006701, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, BioSample:SAMN03472517, BioSample:SAMN03473090, BioSample:SAMN10988111, cancercelllines:CVCL_1611, Cell_Model_Passport:SIDM01779, CGH-DB:133-1, Cosmic:1187287, DepMap:ACH-000761, EGA:EGAS00001000610, GEO:GSM887461, GEO:GSM888541, IARC_TP53:28221, JCRB:JCRB0821, LiGeA:CCLE_199, LINCS_LDP:LCL-1899, PharmacoDB:NUGC2_1172_2019, Progenetix:CVCL_1611, Wikidata:Q54931159 |
|
|
CVCL_1611 |
2026-09-12 05:56:34 |
3 |
NUGC-4
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_3082
|
Homo sapiens (Human)
|
Gastric signet ring cell adenocarcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1370612 PMID:1778766 PMID:2474525 PMID:3172586 PMID:9290701 PMID:11314020 PMID:15723654 PMID:15900046 PMID:19132987 PMID:20215515 PMID:22460905 PMID:24587255 PMID:24807215 PMID:25343454 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:29435981 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
NUGC4, NU-GC-4, Nagoya University-Gastric Cancer-4 |
|
|
BTO:BTO_0005917, CLO:CLO_0050789, EFO:EFO_0006703, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN01821711, BioSample:SAMN03473124, BioSample:SAMN10987867, cancercelllines:CVCL_3082, Cell_Model_Passport:SIDM00570, CGH-DB:135-1, ChEMBL-Cells:CHEMBL3307267, ChEMBL-Targets:CHEMBL613519, Cosmic:1187289, Cosmic:1329186, Cosmic:1460702, Cosmic:1518257, Cosmic:1890473, Cosmic:2009530, Cosmic:2484971, Cosmic:2807639, Cosmic-CLP:1298357, DepMap:ACH-000674, EGA:EGAS00001000610, EGA:EGAS00001000978, FANTOM5_SSTAR:10483-107A6, GDSC:1298357, GEO:GSM552368, GEO:GSM827575, GEO:GSM844667, GEO:GSM887463, GEO:GSM888543, GEO:GSM1374777, GEO:GSM1670288, IARC_TP53:25015, JCRB:JCRB0834, LiGeA:CCLE_273, LINCS_LDP:LCL-2001, PharmacoDB:NUGC4_1174_2019, PRIDE:PXD030304, Progenetix:CVCL_3082, PubChem_Cell_line:CVCL_3082, RCB:RCB1939, TKG:TKG 0449, Wikidata:Q54931165 |
|
|
CVCL_3082 |
2026-09-12 05:56:34 |
11 |
PLC/PRF/5
Resource Report
Resource Website
500+ mentions
Discontinued
|
RRID:CVCL_0485
|
Homo sapiens (Human)
|
Adult hepatocellular carcinoma
|
Caution: Often called PLC8024 in Chinese literature probably because of a concatenation between PLC/PRF/5 and ATCC-8024., Karyotypic information: Has lost chromosome Y., Virology: Susceptible to infection by adenovirus types 40 (Ad40) and 41 (Ad41) (PubMed=1317878)., Virology: Contains at least 7 copies of integrated hepatitis B virus (HBV) genomes. Secretes hepatitis virus B surface antigen (HBsAg) but no other HBV proteins (PubMed=6302689; PubMed=6317496)., Population: African; Shangaan., Part of: MD Anderson Cell Lines Project., Part of: Liver Cancer Model Repository (LIMORE)., Part of: JFCR45 cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:63998 PMID:184551 PMID:187208 PMID:1317878 PMID:1661347 PMID:2414854 PMID:2439335 PMID:2542205 PMID:2992761 PMID:2992762 PMID:3023526 PMID:3431441 PMID:6160110 PMID:6225510 PMID:6248960 PMID:6268737 PMID:6275024 PMID:6288577 PMID:6302689 PMID:6317496 PMID:6555060 PMID:6889516 PMID:7874267 PMID:8050184 PMID:8224613 PMID:8389256 PMID:8835345 PMID:9023415 PMID:9178645 PMID:9290701 PMID:9359923 PMID:10523694 PMID:11050057 PMID:12029633 PMID:15767549 PMID:20069059 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23505090 PMID:23887712 PMID:25485619 PMID:25574106 PMID:25877200 PMID:26589293 PMID:28196595 PMID:29892436 PMID:30894373 PMID:31063779 PMID:31068700 PMID:31378681
|
Cancer cell line
|
Male |
PLC-PRF-5, PLC PRF 5, PLC/PRF5, PLCPRF5, PLC-8024, PLC8024, PLC, Alexander cells, Alexander, Primary Liver Carcinoma/Poliomyelitis Research Foundation/5 |
|
|
BTO:BTO_0003492, CLO:CLO_0008458, CLO:CLO_0008459, EFO:EFO_0006291, MCCL:MCC:0000384, CLDB:cl3914, CLDB:cl3915, CLDB:cl3916, CLDB:cl5248, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CRL-8024, BCRC:60223, BCRJ:0274, BioGRID_ORCS_Cell_line:484, BioSample:SAMN03471130, BioSample:SAMN03473236, BioSample:SAMN10988112, cancercelllines:CVCL_0485, CCRID:1101HUM-PUMC000674, CCRID:1102HUM-NIFDC00071, CCRID:3101HUMTCHu119, CCRID:4201HUM-CCTCC00644, Cell_Model_Passport:SIDM01318, CGH-DB:9070-4, ChEMBL-Cells:CHEMBL3308140, ChEMBL-Targets:CHEMBL1075561, CLS:300315, Cosmic:721061, Cosmic:808505, Cosmic:871514, Cosmic:873402, Cosmic:925349, Cosmic:945155, Cosmic:948065, Cosmic:1019318, Cosmic:1351513, Cosmic:1518224, Cosmic:2023861, Cosmic:2162538, Cosmic:2321033, Cosmic:2674231, Cosmic:2773187, DepMap:ACH-001318, ECACC:85061113, EGA:EGAS00001000610, GDSC:925349, GEO:GSM207051, GEO:GSM565881, GEO:GSM827153, GEO:GSM886865, GEO:GSM887520, GEO:GSM887930, GEO:GSM888602, GEO:GSM936773, GEO:GSM2551580, GEO:GSM2551581, IARC_TP53:107, IARC_TP53:30016, IZSLER:BS TCL 122, JCRB:IFO50069, JCRB:JCRB0406, KCB:KCB 200785YJ, KCLB:28024, LiGeA:CCLE_292, LIMORE:PLC8024, LIMORE:PLCPRF5, LINCS_LDP:LCL-1942, NCBI_Iran:C145, PharmacoDB:PLCPRF5_1274_2019, Progenetix:CVCL_0485, PubChem_Cell_line:CVCL_0485, RCB:RCB1887, TKG:TKG 0376, TOKU-E:2898, Ubigene:YC-C125, Wikidata:Q54947574 |
|
|
CVCL_0485 |
2026-09-12 05:58:10 |
590 |
NH-6
Resource Report
Resource Website
1+ mentions
|
JCRB Cat# JCRB0832, RRID:CVCL_1606
|
Homo sapiens (Human)
|
Adrenal gland neuroblastoma
|
Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2004381 PMID:9290701 PMID:20164919 PMID:22460905 PMID:26589293 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Female |
NH6, Neuroblastoma-6 |
JCRB |
JCRB0832 |
CLO:CLO_0050089, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, BioSample:SAMN01821710, BioSample:SAMN03472525, BioSample:SAMN10987623, cancercelllines:CVCL_1606, Cell_Model_Passport:SIDM01391, ChEMBL-Cells:CHEMBL3308801, ChEMBL-Targets:CHEMBL1075551, Cosmic:925344, DepMap:ACH-000203, GEO:GSM887455, GEO:GSM888535, IARC_TP53:27701, JCRB:JCRB0832, LiGeA:CCLE_072, PharmacoDB:NH6_1158_2019, Progenetix:CVCL_1606, PubChem_Cell_line:CVCL_1606, RCB:RCB2109, TKG:TKG 0468, Wikidata:Q54930503 |
|
|
CVCL_1606 |
2026-09-12 05:56:11 |
1 |
NH-6
Resource Report
Resource Website
1+ mentions
|
TKG Cat# TKG 0468, RRID:CVCL_1606
|
Homo sapiens (Human)
|
Adrenal gland neuroblastoma
|
Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2004381 PMID:9290701 PMID:20164919 PMID:22460905 PMID:26589293 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Female |
NH6, Neuroblastoma-6 |
TKG |
TKG 0468 |
CLO:CLO_0050089, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, BioSample:SAMN01821710, BioSample:SAMN03472525, BioSample:SAMN10987623, cancercelllines:CVCL_1606, Cell_Model_Passport:SIDM01391, ChEMBL-Cells:CHEMBL3308801, ChEMBL-Targets:CHEMBL1075551, Cosmic:925344, DepMap:ACH-000203, GEO:GSM887455, GEO:GSM888535, IARC_TP53:27701, JCRB:JCRB0832, LiGeA:CCLE_072, PharmacoDB:NH6_1158_2019, Progenetix:CVCL_1606, PubChem_Cell_line:CVCL_1606, RCB:RCB2109, TKG:TKG 0468, Wikidata:Q54930503 |
|
|
CVCL_1606 |
2026-09-12 05:56:11 |
1 |
PaTu 8902
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1845
|
Homo sapiens (Human)
|
Pancreatic adenocarcinoma
|
Population: Caucasian., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8194712 PMID:8287116 PMID:10700188 PMID:11668190 PMID:15126341 PMID:15688027 PMID:22460905 PMID:25167228 PMID:25485619 PMID:25877200 PMID:26216984 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
PA-TU-8902, PATU-8902, PaTu8902, PATU8902, 8902, PaCL2 |
|
|
BTO:BTO_0006485, CLO:CLO_0008382, EFO:EFO_0006729, CLDB:cl3860, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:191, BioSample:SAMN03473078, BioSample:SAMN10987803, cancercelllines:CVCL_1845, Cell_Model_Passport:SIDM00455, Cosmic:873004, Cosmic:948381, Cosmic:2434100, Cosmic-CLP:1298526, DepMap:ACH-000599, DSMZ:ACC-179, DSMZCellDive:ACC-179, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1298526, GEO:GSM206534, GEO:GSM887502, GEO:GSM888584, GEO:GSM1670336, IARC_TP53:2966, IARC_TP53:25073, LiGeA:CCLE_026, LINCS_LDP:LCL-1744, NCBI_Iran:C557, PharmacoDB:PATU8902_1236_2019, PRIDE:PXD030304, Progenetix:CVCL_1845, Wikidata:Q54938318 |
|
|
CVCL_1845 |
2026-09-12 05:57:25 |
26 |
PaTu 8988t
Resource Report
Resource Website
50+ mentions
|
RRID:CVCL_1847
|
Homo sapiens (Human)
|
Pancreatic adenocarcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: ENCODE project common cell types; tier 3., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1348891 PMID:10408907 PMID:10700188 PMID:11668190 PMID:15126341 PMID:15688027 PMID:20215515 PMID:22460905 PMID:22585861 PMID:25167228 PMID:25485619 PMID:25877200 PMID:26216984 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
PA-TU-8988T, PaTu8988t, PaTu8988T, PATU8988T, PaTu 8988 T, PaTu-8988t, PATU-8988T, PATU-T, PA-TU T, 8988T, PaCL4 |
|
|
BTO:BTO_0005878, CLO:CLO_0008384, EFO:EFO_0005713, CLDB:cl3862, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:986, BioSample:SAMN03473157, BioSample:SAMN10988386, cancercelllines:CVCL_1847, Cell_Model_Passport:SIDM00453, ChEMBL-Cells:CHEMBL4295420, ChEMBL-Targets:CHEMBL4296488, CLS:305133, Cosmic:873006, Cosmic:948382, Cosmic:1524020, Cosmic:1995611, Cosmic:2046531, Cosmic:2434111, Cosmic-CLP:1240201, DepMap:ACH-000023, DSMZ:ACC-162, DSMZCellDive:ACC-162, EGA:EGAS00001000610, EGA:EGAS00001000978, ENCODE:ENCBS158AAA, GDSC:1240201, GEO:GSM206535, GEO:GSM385524, GEO:GSM385535, GEO:GSM816667, GEO:GSM827178, GEO:GSM887504, GEO:GSM888586, GEO:GSM16703371, IGRhCellID:PA-TU-8988T%20GEO, LiGeA:CCLE_005, LINCS_LDP:LCL-1746, PharmacoDB:PATU8988T_1238_2019, PRIDE:PXD030304, Progenetix:CVCL_1847, PubChem_Cell_line:CVCL_1847, Wikidata:Q54938330 |
|
|
CVCL_1847 |
2026-09-12 05:57:25 |
52 |
PC-3
Resource Report
Resource Website
1000+ mentions
Discontinued
|
RRID:CVCL_0035
|
Homo sapiens (Human)
|
Prostate carcinoma
|
Caution: There seem to be two distinct cell lines which were assigned NCBI_Iran catalog number C427., Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: JFCR39 cancer cell line panel., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:447482 PMID:571045 PMID:1873816 PMID:3335022 PMID:3518877 PMID:6244232 PMID:8104329 PMID:8687134 PMID:9018337 PMID:9331090 PMID:9460501 PMID:9823299 PMID:10687853 PMID:10700174 PMID:10702678 PMID:10754530 PMID:10972993 PMID:11135431 PMID:11172901 PMID:11304728 PMID:11414198 PMID:11416159 PMID:12606952 PMID:12725112 PMID:14518029 PMID:15486987 PMID:15748285 PMID:16957166 PMID:17088437 PMID:17254797 PMID:17440963 PMID:19372543 PMID:20164919 PMID:21432867 PMID:22068913 PMID:22275356 PMID:22336246 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22628656 PMID:23671654 PMID:23856246 PMID:23933261 PMID:24279929 PMID:24504141 PMID:24670534 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26256267 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28196595 PMID:29194687 PMID:30244336 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31404090 PMID:31733513 PMID:31978347 PMID:32968452 PMID:35839778 PMID:38861359
|
Cancer cell line
|
Male |
PC3, PC.3 |
|
|
BTO:BTO_0001061, CLO:CLO_0008395, CLO:CLO_0051535, EFO:EFO_0002074, MCCL:MCC:0000380, CLDB:cl3881, CLDB:cl3883, Abcam:ab275472, AddexBio:C0019002/61, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1435, ATCC:CRL-7934, BCRC:60122, BCRJ:0269, BioGRID_ORCS_Cell_line:193, BioSample:SAMN01821588, BioSample:SAMN01821653, BioSample:SAMN01821713, BioSample:SAMN03472063, BioSample:SAMN05292438, BioSample:SAMN10988356, cancercelllines:CVCL_0035, CCRID:1101HUM-PUMC000115, CCRID:3101HUMSCSP532, CCRID:3101HUMTCHu158, CCRID:4201HUM-CCTCC00095, CCTCC:GDC0095, Cell_Model_Passport:SIDM00088, ChEMBL-Cells:CHEMBL3307570, ChEMBL-Targets:CHEMBL390, CLS:300312, Cosmic:688118, Cosmic:704849, Cosmic:713868, Cosmic:719680, Cosmic:721366, Cosmic:721556, Cosmic:755297, Cosmic:759894, Cosmic:801350, Cosmic:809225, Cosmic:850414, Cosmic:869157, Cosmic:873002, Cosmic:875892, Cosmic:876396, Cosmic:897455, Cosmic:905934, Cosmic:911997, Cosmic:918502, Cosmic:920968, Cosmic:921048, Cosmic:922551, Cosmic:923957, Cosmic:943175, Cosmic:948379, Cosmic:949249, Cosmic:974299, Cosmic:1028650, Cosmic:1028702, Cosmic:1071477, Cosmic:1075273, Cosmic:1092627, Cosmic:1172628, Cosmic:1175888, Cosmic:1188436, Cosmic:1212489, Cosmic:1219448, Cosmic:1305380, Cosmic:1312367, Cosmic:1330910, Cosmic:1436048, Cosmic:1689714, Cosmic:1995613, Cosmic:1998469, Cosmic:2301588, Cosmic:2580130, Cosmic:2585153, Cosmic:2585230, Cosmic:2621167, Cosmic:2651772, Cosmic:2669172, Cosmic:2674178, Cosmic-CLP:905934, DepMap:ACH-000090, DSMZ:ACC-465, DSMZCellDive:ACC-465, ECACC:90112714, EGA:EGAS00001000610, EGA:EGAS00001000978, ENCODE:ENCBS420VDY, ENCODE:ENCBS451OVM, ENCODE:ENCBS504WVV, ENCODE:ENCBS596CTT, ENCODE:ENCBS608AAA, ENCODE:ENCBS609AAA, FANTOM5_SSTAR:10439-106E7, FCS-free:16-2-16-3-6-4, GDSC:905934, GEO:GSM2171, GEO:GSM50225, GEO:GSM50289, GEO:GSM91930, GEO:GSM142459, GEO:GSM142460, GEO:GSM482670, GEO:GSM525804, GEO:GSM595615, GEO:GSM648823, GEO:GSM743480, GEO:GSM750835, GEO:GSM784792, GEO:GSM799370, GEO:GSM799433, GEO:GSM844674, GEO:GSM844675, GEO:GSM847110, GEO:GSM887506, GEO:GSM888588, GEO:GSM1153442, GEO:GSM1178542, GEO:GSM1178543, GEO:GSM1181274, GEO:GSM1181303, GEO:GSM1374817, GEO:GSM1374818, GEO:GSM1670339, GEO:GSM2124647, GEO:GSM4962583, GEO:GSM4962584, GEO:GSM4962585, GEO:GSM4962586, GEO:GSM4962587, GEO:GSM4962588, GEO:GSM4962589, GEO:GSM4962590, GEO:GSM4962591, GEO:GSM7701363, GEO:GSM7701364, Hysigen:TCH-C297, IARC_TP53:752, IARC_TP53:21276, ICLC:HTL97018, IZSLER:BS TCL 175, JCRB:JCRB9110, KCB:KCB 200725YJ, KCLB:21435, LiGeA:CCLE_525, LINCS_HMS:50454, LINCS_LDP:LCL-1299, Lonza:125, MeSH:D000078722, NCBI_Iran:C427, NCI-DTP:PC-3, PharmacoDB:PC3_1248_2019, PRIDE:PRD000228, PRIDE:PRD000597, PRIDE:PXD000661, PRIDE:PXD002107, PRIDE:PXD003105, PRIDE:PXD003539, PRIDE:PXD005940, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD008184, PRIDE:PXD030304, PRIDE:PXD032264, Progenetix:CVCL_0035, PubChem_Cell_line:CVCL_0035, RCB:RCB2145, SKY/M-FISH/CGH:2799, TKG:TKG 0600, TOKU-E:2868, Ubigene:YC-C010, Wikidata:Q7118483 |
|
|
CVCL_0035 |
2026-09-12 05:57:27 |
4313 |
OS-RC-2
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1626
|
Homo sapiens (Human)
|
Clear cell renal cell carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:4008433 PMID:14534724 PMID:15604581 PMID:20164919 PMID:26589293 PMID:27397505 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
OSRC2, RC-2 |
|
|
BTO:BTO_0002403, CLO:CLO_0050889, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:512, BioSample:SAMN03472222, BioSample:SAMN10987712, cancercelllines:CVCL_1626, CCRID:1101HUM-PUMC000292, CCRID:3101HUMTCHu40, Cell_Model_Passport:SIDM00239, ChEMBL-Cells:CHEMBL3308274, ChEMBL-Targets:CHEMBL2366188, CLS:305086, Cosmic:909250, Cosmic-CLP:909250, DepMap:ACH-000159, EGA:EGAS00001000978, FANTOM5_SSTAR:10411-106B6, GDSC:909250, GEO:GSM1670310, IARC_TP53:21604, KCB:KCB 200779YJ, LiGeA:CCLE_815, LINCS_LDP:LCL-1768, PharmacoDB:OSRC2_1203_2019, PRIDE:PXD030304, Progenetix:CVCL_1626, PubChem_Cell_line:CVCL_1626, RCB:RCB0735, Wikidata:Q54936539 |
|
|
CVCL_1626 |
2026-09-12 05:56:57 |
178 |
OV-90
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_3768
|
Homo sapiens (Human)
|
Ovarian adenocarcinoma
|
Population: Caucasian., Part of: OCCP ovarian cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:10949993 PMID:11641787 PMID:20204287 PMID:20215515 PMID:22141344 PMID:22328975 PMID:22460905 PMID:22585861 PMID:22710073 PMID:23839242 PMID:24023729 PMID:24675677 PMID:25230021 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27235858 PMID:27397505 PMID:28196595 PMID:28273451 PMID:30485824 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
OV90 |
|
|
BTO:BTO_0004852, CLO:CLO_0008276, EFO:EFO_0002311, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-3585, ATCC:CRL-11732, BioGRID_ORCS_Cell_line:393, BioSample:SAMN03471308, BioSample:SAMN10987765, cancercelllines:CVCL_3768, CancerTools:161765, Cell_Model_Passport:SIDM01141, ChEMBL-Cells:CHEMBL4295466, ChEMBL-Targets:CHEMBL4296481, CLS:305849, Cosmic:1102815, Cosmic:1113283, Cosmic:1139219, Cosmic:1305311, Cosmic:1709257, Cosmic:2186586, Cosmic-CLP:1240197, DepMap:ACH-000291, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1240197, GEO:GSM274704, GEO:GSM659389, GEO:GSM711702, GEO:GSM784576, GEO:GSM851926, GEO:GSM887483, GEO:GSM888564, GEO:GSM1001427, GEO:GSM1001428, GEO:GSM1001492, GEO:GSM1291148, GEO:GSM1374800, GEO:GSM1670314, GEO:GSM2474988, IARC_TP53:20198, IGRhCellID:OV90, LiGeA:CCLE_009, LINCS_LDP:LCL-1523, PharmacoDB:OV90_1210_2019, PRIDE:PXD030304, Progenetix:CVCL_3768, PubChem_Cell_line:CVCL_3768, Wikidata:Q54936833 |
|
|
CVCL_3768 |
2026-09-12 05:57:02 |
31 |
OVCA429
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_3936
|
Homo sapiens (Human)
|
Ovarian cystadenocarcinoma
|
Part of: MD Anderson Cell Lines Project.
|
PMID:1536252 PMID:6346879 PMID:7028788 PMID:10318951 PMID:10972993 PMID:12080474 PMID:12960427 PMID:16380993 PMID:16382445 PMID:19926575 PMID:20204287 PMID:20596667 PMID:22710073 PMID:25485619 PMID:25877200 PMID:26589293 PMID:28196595 PMID:30485824
|
Cancer cell line
|
Female |
OVCA 429, OvCA 429, OVCA-429, OVCAR-429, OVCAR 429, OVCAR429, OV429 |
|
|
BTO:BTO_0002564, EFO:EFO_0006721, ArrayExpress:E-MTAB-2706, BioSample:SAMN03470937, cancercelllines:CVCL_3936, Cosmic:924146, Cosmic:927567, Cosmic:1223315, Cosmic:1328064, Cosmic:1434898, Cosmic:2074245, EGA:EGAS00001000610, GEO:GSM95439, GEO:GSM659391, GEO:GSM711704, GEO:GSM851929, IARC_TP53:28487, PharmacoDB:OvCA429_1214_2019, Progenetix:CVCL_3936, Wikidata:Q54936983 |
|
|
CVCL_3936 |
2026-09-12 05:57:04 |
12 |
OVCAR-5
Resource Report
Resource Website
100+ mentions
Possibly Misclassified
|
RRID:CVCL_1628
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Possibly misclassified. Originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin (PubMed=27353327)..
|
PMID:1348364 PMID:2041050 PMID:2307530 PMID:3335022 PMID:3930572 PMID:6385258 PMID:7718330 PMID:9041185 PMID:9331090 PMID:10700174 PMID:12417041 PMID:12960427 PMID:15748285 PMID:17088437 PMID:19372543 PMID:19926575 PMID:20164919 PMID:20204287 PMID:22068913 PMID:22328975 PMID:22336246 PMID:22347499 PMID:22384151 PMID:22585861 PMID:22628656 PMID:22710073 PMID:23415752 PMID:23856246 PMID:23933261 PMID:24023729 PMID:24279929 PMID:24434149 PMID:24670534 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27235858 PMID:27353327 PMID:27377824 PMID:27397505 PMID:27561551 PMID:27807467 PMID:28196595 PMID:28273451 PMID:30485824 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31733513 PMID:35681748 PMID:35839778 PMID:38861359
|
Cancer cell line
|
Female |
OVCAR 5, NIH:OVCAR-5, OVCAR.5, OVCAR5, Ovcar5, OVCA5 |
|
|
BTO:BTO_0001870, CLO:CLO_0008280, EFO:EFO_0005443, CLDB:cl3781, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:982, BioSample:SAMN03472888, BioSample:SAMN10989589, cancercelllines:CVCL_1628, Cell_Model_Passport:SIDM00091, ChEMBL-Cells:CHEMBL3307565, ChEMBL-Targets:CHEMBL614214, CLS:305616, Cosmic:875861, Cosmic:897435, Cosmic:905969, Cosmic:974297, Cosmic:1044241, Cosmic:1092625, Cosmic:1093554, Cosmic:1102824, Cosmic:1175885, Cosmic:1305314, Cosmic:1312356, Cosmic:1436035, Cosmic:1523763, Cosmic:1707573, Cosmic:1709255, Cosmic:1995605, Cosmic:1998467, Cosmic:2186583, Cosmic-CLP:905969, DepMap:ACH-001151, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:905969, GEO:GSM2126, GEO:GSM50221, GEO:GSM50285, GEO:GSM185139, GEO:GSM185140, GEO:GSM659394, GEO:GSM711709, GEO:GSM743476, GEO:GSM743493, GEO:GSM743512, GEO:GSM743513, GEO:GSM743514, GEO:GSM743515, GEO:GSM743516, GEO:GSM743517, GEO:GSM743518, GEO:GSM743519, GEO:GSM743520, GEO:GSM743521, GEO:GSM743522, GEO:GSM743523, GEO:GSM743524, GEO:GSM750830, GEO:GSM784573, GEO:GSM799365, GEO:GSM799428, GEO:GSM844671, GEO:GSM847108, GEO:GSM851936, GEO:GSM1153437, GEO:GSM1178525, GEO:GSM1178526, GEO:GSM1181280, GEO:GSM1181287, GEO:GSM1340587, GEO:GSM1374802, GEO:GSM1670319, GEO:GSM2124678, GEO:GSM2474993, Millipore:SCC259, NCI-DTP:OVCAR-5, PharmacoDB:OVCAR5_1219_2019, PRIDE:PXD003539, PRIDE:PXD003668, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD030304, Progenetix:CVCL_1628, PubChem_Cell_line:CVCL_1628, SKY/M-FISH/CGH:2818, Wikidata:Q54937011 |
|
|
CVCL_1628 |
2026-09-12 05:57:04 |
213 |
OVCA420
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_3935
|
Homo sapiens (Human)
|
Ovarian serous adenocarcinoma
|
Population: African American., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1536252 PMID:6346879 PMID:7028788 PMID:10318951 PMID:10972993 PMID:11793438 PMID:12960427 PMID:20204287 PMID:22115851 PMID:22710073 PMID:23415752 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28273451 PMID:30894373 PMID:30971826 PMID:35839778
|
Cancer cell line
|
Female |
OVCA 420, OvCa 420, OVCA-420, OVCAR-420, OVCAR 420, OVCAR420 |
|
|
BTO:BTO_0002563, EFO:EFO_0006720, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:980, BioSample:SAMN03471874, cancercelllines:CVCL_3935, Cell_Model_Passport:SIDM00967, Cosmic:924145, Cosmic:927566, Cosmic-CLP:1480364, DepMap:ACH-002181, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1480364, GEO:GSM659390, GEO:GSM711703, GEO:GSM851928, GEO:GSM1340585, GEO:GSM1341130, GEO:GSM1670315, GEO:GSM2474990, IARC_TP53:28490, PharmacoDB:OVCA420_1213_2019, PRIDE:PXD030304, Wikidata:Q54936981 |
|
|
CVCL_3935 |
2026-09-12 05:57:04 |
8 |
OVCA432
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_3769
|
Homo sapiens (Human)
|
Ovarian serous adenocarcinoma
|
|
PMID:1536252 PMID:6346879 PMID:7028788 PMID:7836420 PMID:10318951 PMID:10972993 PMID:11793438 PMID:12960427 PMID:20204287 PMID:22585861 PMID:22710073 PMID:23415752 PMID:25485619 PMID:25877200 PMID:26589293 PMID:28273451
|
Cancer cell line
|
Female |
OV-CA 432, OVCA 432, OvCA 432, OVCA-432, OVCA432_Bast, OVCAR-432, OVCAR 432, OVCAR432 |
|
|
BTO:BTO_0002565, CLO:CLO_0008278, EFO:EFO_0006722, CLDB:cl3778, ArrayExpress:E-MTAB-2706, BioSample:SAMN03470830, cancercelllines:CVCL_3769, Cosmic:924147, Cosmic:991322, Cosmic:1524354, EGA:EGAS00001000610, GDSC:1480366, GEO:GSM659392, GEO:GSM711705, GEO:GSM851930, GEO:GSM2474991, IARC_TP53:28488, PharmacoDB:OvCA432_1215_2019, Wikidata:Q54936988 |
|
|
CVCL_3769 |
2026-09-12 05:57:04 |
9 |
OVCAR-3
Resource Report
Resource Website
1000+ mentions
Discontinued
|
RRID:CVCL_0465
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Caucasian., Part of: OCCP ovarian cancer cell line panel., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JFCR39 cancer cell line panel., Part of: ENCODE project common cell types; tier 3., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
|
PMID:1348364 PMID:1892748 PMID:2041050 PMID:2307530 PMID:2653399 PMID:3335022 PMID:3930572 PMID:6372095 PMID:6385258 PMID:6604576 PMID:8557231 PMID:9041185 PMID:9331090 PMID:9698466 PMID:10700174 PMID:11414198 PMID:11793438 PMID:12417041 PMID:12960427 PMID:15748285 PMID:16382445 PMID:17088437 PMID:18277095 PMID:18560578 PMID:19372543 PMID:19926575 PMID:20164919 PMID:20204287 PMID:20215515 PMID:21912889 PMID:22068913 PMID:22328975 PMID:22336246 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22585861 PMID:22628656 PMID:22710073 PMID:23172893 PMID:23351415 PMID:23415752 PMID:23839242 PMID:23856246 PMID:23933261 PMID:24023729 PMID:24279929 PMID:24434149 PMID:24670534 PMID:25230021 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26169745 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27235858 PMID:27377824 PMID:27397505 PMID:27561551 PMID:27807467 PMID:28100988 PMID:28196595 PMID:28273451 PMID:30485824 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31733513 PMID:31978347 PMID:32612269 PMID:35839778 PMID:38861359
|
Cancer cell line
|
Female |
Ovcar-3, OVCAR 3, OVCAR.3, NIH:OVCAR-3, NIH:Ovcar-3, NIH:OVCAR3, NIH-OVCAR-3, NIHOVCAR3, OVCAR3, Ovcar3 |
|
|
BTO:BTO_0000812, CLO:CLO_0008171, CLO:CLO_0008279, CLO:CLO_0051451, EFO:EFO_0003061, MCCL:MCC:0000363, CLDB:cl3712, CLDB:cl3780, CLDB:cl5237, Abcam:ab275471, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-161, BCRC:60551, BCRJ:0317, BioGRID_ORCS_Cell_line:981, BioSample:SAMN01821585, BioSample:SAMN03471390, BioSample:SAMN05292457, BioSample:SAMN10987888, cancercelllines:CVCL_0465, CCRID:1101HUM-PUMC000362, CCRID:3101HUMTCHu228, CCRID:4201HUM-CCTCC00119, CCTCC:GDC0119, Cell_Model_Passport:SIDM00105, ChEMBL-Cells:CHEMBL3307564, ChEMBL-Targets:CHEMBL614213, CLS:300307, Cosmic:687926, Cosmic:688104, Cosmic:755845, Cosmic:809113, Cosmic:844347, Cosmic:845142, Cosmic:875859, Cosmic:897433, Cosmic:905933, Cosmic:906577, Cosmic:920357, Cosmic:924144, Cosmic:927564, Cosmic:949227, Cosmic:974296, Cosmic:991321, Cosmic:1044239, Cosmic:1092623, Cosmic:1093553, Cosmic:1102816, Cosmic:1139222, Cosmic:1175883, Cosmic:1218877, Cosmic:1305312, Cosmic:1312192, Cosmic:1312354, Cosmic:1436033, Cosmic:1482525, Cosmic:1524357, Cosmic:1709250, Cosmic:1998465, Cosmic:2186584, Cosmic-CLP:905933, DepMap:ACH-000001, EGA:EGAS00001000610, EGA:EGAS00001000978, ENCODE:ENCBS419ENC, GDSC:905933, GEO:GSM2122, GEO:GSM50219, GEO:GSM50282, GEO:GSM95463, GEO:GSM185135, GEO:GSM185136, GEO:GSM274703, GEO:GSM313683, GEO:GSM459733, GEO:GSM459741, GEO:GSM645843, GEO:GSM659393, GEO:GSM711708, GEO:GSM743474, GEO:GSM743498, GEO:GSM750817, GEO:GSM784564, GEO:GSM799362, GEO:GSM799363, GEO:GSM799425, GEO:GSM799426, GEO:GSM844668, GEO:GSM847106, GEO:GSM851934, GEO:GSM887456, GEO:GSM888536, GEO:GSM1001493, GEO:GSM1153434, GEO:GSM1153435, GEO:GSM1178508, GEO:GSM1178509, GEO:GSM1181276, GEO:GSM1181278, GEO:GSM1186813, GEO:GSM1186814, GEO:GSM1186815, GEO:GSM1186816, GEO:GSM1186827, GEO:GSM1291149, GEO:GSM1374771, GEO:GSM1374772, GEO:GSM1374773, GEO:GSM1670317, GEO:GSM2124645, GEO:GSM2474989, IARC_TP53:1417, ICLC:HTL97004, IGRhCellID:OVCAR3, IZSLER:BS TCL 131, KCB:KCB 2006106YJ, KCLB:30161, LiGeA:CCLE_502, LINCS_LDP:LCL-1522, Lonza:31, MetaboLights:MTBLS150, MetaboLights:MTBLS152, Millipore:SCC257, NCBI_Iran:C430, NCI-DTP:OVCAR-3, PharmacoDB:OVCAR3_1217_2019, PRIDE:PXD003105, PRIDE:PXD003539, PRIDE:PXD003668, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD030304, Progenetix:CVCL_0465, PubChem_Cell_line:CVCL_0465, RCB:RCB2135, SKY/M-FISH/CGH:2742, TKG:TKG 0602, TOKU-E:2754, Ubigene:YC-D019, Wikidata:Q54937005 |
|
|
CVCL_0465 |
2026-09-12 05:57:04 |
1642 |
OVISE
Resource Report
Resource Website
10+ mentions
Discontinued Discontinued
|
RRID:CVCL_3116
|
Homo sapiens (Human)
|
Ovarian clear cell adenocarcinoma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7535723 PMID:9328139 PMID:11121861 PMID:15677628 PMID:17671176 PMID:20081105 PMID:20215515 PMID:22460905 PMID:22705003 PMID:23839242 PMID:24023729 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26388441 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27397505 PMID:27561551 PMID:28196595 PMID:30485824 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
|
|
|
BTO:BTO_0003498, CLO:CLO_0037097, EFO:EFO_0006724, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:983, BioSample:SAMN02800475, BioSample:SAMN03472858, BioSample:SAMN10988266, cancercelllines:CVCL_3116, Cell_Model_Passport:SIDM00564, CGH-DB:330-2, Cosmic:1223316, Cosmic:1328065, Cosmic:1434893, Cosmic:1708377, Cosmic:1995606, Cosmic:2074246, Cosmic:2482699, Cosmic-CLP:1240198, DepMap:ACH-000527, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1240198, GEO:GSM416678, GEO:GSM659395, GEO:GSM827222, GEO:GSM888567, GEO:GSM1176280, GEO:GSM1670321, IARC_TP53:30140, JCRB:JCRB1043, JCRB:NIHS0296, JCRB:NIHS0338, LiGeA:CCLE_251, LINCS_LDP:LCL-1524, PharmacoDB:OVISE_1222_2019, PRIDE:PXD000901, PRIDE:PXD003105, PRIDE:PXD003668, PRIDE:PXD030304, Progenetix:CVCL_3116, Wikidata:Q54937026 |
|
|
CVCL_3116 |
2026-09-12 05:57:04 |
14 |
OVCAR-4
Resource Report
Resource Website
50+ mentions
|
RRID:CVCL_1627
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1348364 PMID:2041050 PMID:2307530 PMID:3335022 PMID:3930572 PMID:6372095 PMID:6385258 PMID:7718330 PMID:9041185 PMID:9331090 PMID:10700174 PMID:12080474 PMID:12960427 PMID:15748285 PMID:17088437 PMID:19372543 PMID:20164919 PMID:22068913 PMID:22336246 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22628656 PMID:23839242 PMID:23856246 PMID:23933261 PMID:24023729 PMID:24279929 PMID:24670534 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27235858 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28196595 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31733513 PMID:31978347 PMID:32612269 PMID:35839778 PMID:35918200 PMID:38861359
|
Cancer cell line
|
Female |
OVCAR 4, NIH:OVCAR-4, NIH:OVCAR4, OVCAR.4, OVCAR4, Ovcar4 |
|
|
BTO:BTO_0002561, CLO:CLO_0037096, EFO:EFO_0005442, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03472889, BioSample:SAMN10987768, cancercelllines:CVCL_1627, Cell_Model_Passport:SIDM00092, ChEMBL-Cells:CHEMBL3307517, ChEMBL-Targets:CHEMBL614051, Cosmic:688105, Cosmic:875860, Cosmic:897434, Cosmic:905990, Cosmic:974295, Cosmic:1044240, Cosmic:1092624, Cosmic:1175884, Cosmic:1305313, Cosmic:1312355, Cosmic:1436034, Cosmic:1998466, Cosmic-CLP:905990, DepMap:ACH-000617, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:905990, GEO:GSM2174, GEO:GSM50220, GEO:GSM50284, GEO:GSM185137, GEO:GSM185138, GEO:GSM186442, GEO:GSM186443, GEO:GSM743475, GEO:GSM743494, GEO:GSM750829, GEO:GSM784572, GEO:GSM799364, GEO:GSM799427, GEO:GSM844669, GEO:GSM844670, GEO:GSM847107, GEO:GSM851935, GEO:GSM887484, GEO:GSM888565, GEO:GSM1153436, GEO:GSM1181279, GEO:GSM1181286, GEO:GSM1374801, GEO:GSM1670318, GEO:GSM2124646, IARC_TP53:21085, IARC_TP53:21126, IARC_TP53:30217, LiGeA:CCLE_876, LINCS_LDP:LCL-1697, Millipore:SCC258, NCI-DTP:OVCAR-4, PharmacoDB:OVCAR4_1218_2019, PRIDE:PXD003539, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD030304, Progenetix:CVCL_1627, PubChem_Cell_line:CVCL_1627, SKY/M-FISH/CGH:2817, Wikidata:Q54937010 |
|
|
CVCL_1627 |
2026-09-12 05:57:04 |
53 |
OVK18
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_3770
|
Homo sapiens (Human)
|
Ovarian endometrioid adenocarcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:6584390 PMID:22460905 PMID:22705003 PMID:23839242 PMID:26589293 PMID:27397505 PMID:30485824 PMID:30894373 PMID:30971826 PMID:31068700 PMID:32612269 PMID:35839778
|
Cancer cell line
|
Female |
OVK-18, OVK#18 |
|
|
CLO:CLO_0051452, EFO:EFO_0022631, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:495, BioSample:SAMN03472087, BioSample:SAMN10987740, cancercelllines:CVCL_3770, Cell_Model_Passport:SIDM00238, Cosmic:1066216, Cosmic:1708385, Cosmic-CLP:1480371, DepMap:ACH-000947, EGA:EGAS00001000978, GDSC:1480371, GEO:GSM887486, GEO:GSM888568, GEO:GSM1670322, IARC_TP53:28375, LiGeA:CCLE_457, PharmacoDB:OVK18_1223_2019, PRIDE:PXD030304, Progenetix:CVCL_3770, RCB:RCB1903, TKG:TKG 0323, Wikidata:Q54937028 |
|
|
CVCL_3770 |
2026-09-12 05:57:04 |
2 |